Background: The goal was to explore the protective effect and potential mechanism of amniotic membrane extracts (AME) on the ocular surface exposed to benzalkonium chloride (BAC). Methods: The human corneal epithelial cell (HCEC) line SD-HCEC1s was cultured in 5 groups: normal control (NC), NC + AME, BAC, BAC + NC, and BAC + AME. Cell viability analysis, flow cytometry analysis, real-time polymerase chain reaction (PCR), and western blot were employed to measure changes in cell function. Matrix metalloproteinases (MMPs) and inflammatory cytokines were assayed by enzyme-linked immunosorbent assay (ELISA) and activity assays. Results: Real-time PCR and western blot analysis demonstrated that the expressional level of caspase-8 was increased while the levels of Muc1, Muc4, and Muc16 were decreased after treatment with 0.02% BAC for 1 h. When the SD-HCEC1s were withdrawn from the BAC and switched to media containing 10% AME for 2 days, the expression level of capsase-8 was decreased while the levels of Muc1, Muc4, and Muc16 were increased. Real-time PCR and ELISA demonstrated that the mRNA and protein levels of MMP-1, MMP-3, MMP-13, CXCL1, interleukin (IL)-1β, IL-6, and tumor necrosis factor-alpha (TNF-α) were significantly increased after treatment with 0.02% BAC, whereas those of MMP-8 were decreased. When the 0.02% BAC was withdrawn and the SD-HCEC1s were cultured in 10% AME, the mRNA and protein levels of MMP-1, MMP-3, MMP-13, CXCL1, IL-1β, IL-6, and TNF-α were decreased, while those of MMP-8 were increased. MMP-8 activity assays confirmed that IL-1β and TNF-α downregulated the protein levels of MMP-8. Conclusions: AME protects SD-HCEC1s when stressed in BAC via upregulation of MMP-8 and downregulation of IL-1β and TNF-α. AME may have the potential functions to be employed as a topical adjunctive therapy in eyes chronically exposed to BAC.